Feature

KULR Technology stock continues to consolidate at the $1.50 level. And against a weakening broader markets backdrop, that’s an excellent indicator. Face it, markets over the past seven trading days are getting whacked, with micro and small-caps losing percentages more in value than the mid and large-cap companies. Still, savvy investors that understand market dynamics pay less attention to daily volatility and more to the opportunities that the gyrations present. KULR is an excellent example. The biggest attention grabber is

KULR Technology (NYSE-Amer: KULR) stock is running higher by more than 15% since the start of August. The better news- this rally, despite a few pennies fluctuation, appears to be gaining momentum. And rightfully so. Earlier this week, KULR showed during its Q2 financial report that they are better positioned now than any time in history for potentially exponential growth during the next two quarters. KULR’s bullish sentiment caught the ears of investors, who sent shares higher to $1.77 on

Evofem Biosciences shares have been on fire and show no signs of cooling off. And that’s excellent news for those already long the stock. But, good fortunes for those paying attention to this under-the-radar opportunity are expected to continue. And with the bullish sentiment into last week’s close, newbies to the stock may want to grab a position.  Why? Because from an operational, financial, and legislative perspective, EVFM has never looked better positioned for near and long-term growth. With that

Investors are buying Business Warrior (OTC Pink: BZWR, $BZWR) stock. In fact, demand has sent prices higher by more than 37% since its May lows. But the better news is that momentum to the upside appears to be at BZWR’s back, with shares continuing the bullish pattern by settling with higher lows on above average volume. Investors may be timely to the trade, and with BZWR doing the right things in the right markets at the right time, the path

Shares in Wearable Health Solutions, Inc. (OTC Pink: WHSI, $WHSI) have been on fire, soaring by more than 75% since June. And the better news, at least for those invested, is that the spike higher is likely the precursor of better moves to come. Why? Because despite $WHSI’s micro-cap size, they are playing in the big leagues when it comes to bringing innovative and technologically advanced wearable medical devices to the markets. Better still, they have the right products to

KULR Technology Group (NYSE-AMER: KULR, $KULR) got a nod from the Russell Microcap Index that it will be added to the membership. News sent shares higher by about 9% on Monday. However, investors thinking that’s the only reason for KULR’s impressive move should reconsider that thought. After all, there are numerous value drivers in place, making the investment proposition in KULR more than attractive; they make it compelling.  And here’s the better news. KULR noted that the logistical hurdles imposed

KULR Technology Group (NYSE-AMER: KULR, $KULR) may have had a soft quarter on the revenue front, but by no means should investors think that’s the new norm. Based on its report, far from it. In fact, other than soft revenue numbers attributed to some very challenging pandemic-related logistical hiccups, $KULR showed in its Q1 report that it made significant strides on the operational front that should translate into potentially exponential shareholder value growth during the remainder of 2022. And here’s

KULR Technology Group’s (NYSE-AMER: KULR, $KULR) share price isn’t accurately portraying a company in hypergrowth. In fact, current levels show a significant disconnect from a company fresh off its best year in history with a considerable revenue-generating tailwind at its back. Moreover, growth through Q4, a substantial increase in team power, and new contracts will likely make its best-ever 2021 performance a precursor of better things to come.  There are reasons to be optimistic. The biggest is that KULR is